AIFinancial Timesabout 3 hours ago
Monod Bio Licenses AI Proteins to SignalChem Biotech
1 min read
Monod Bio licensed AI-designed protein technologies to SignalChem Biotech for custom discovery assays. The company announcement details the agreement, which enables SignalChem to use Monod Bio's engineered proteins in its assay development work.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
